Endomembrane System & Vesicular Trafficking
Products Related to Endomembrane System & Vesicular Trafficking(34)
- GC52389Caveolin-1 (82-101) amide (human, mouse, rat, porcine, bovine, ovine) (trifluoroacetate salt)Purity: >95.00%
A synthetic peptide fragment of caveolin-1
- GC908192,3,7,8-TetrachlorodibenzofuranCAS: 51207-31-9Purity: >90.00%
A polychlorinated dibenzofuran and dioxin
- GC908291-Palmitoyl-2-Pyropheophorbide a-sn-glycero-3-PCCAS: 1287795-07-6Purity: >90.00%
A phospholipid-porphyrin conjugate
- GC91977TrkB Agonist Prodrug R13CAS: 1609067-49-3Purity: >95.00%
TrkB agonist prodrug R13 (R13) is a prodrug form of the tropomyosin-related kinase B (TrkB) activator 7,8-dihydroxyflavone.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC52389 | Caveolin-1 (82-101) amide (human, mouse, rat, porcine, bovine, ovine) (trifluoroacetate salt) | - | >95.00% | |
A synthetic peptide fragment of caveolin-1 | ||||
| GC52486 | Ceramide Phosphoethanolamine (bovine) | - | >98.00% | |
A sphingolipid | ||||
| GC62443 | ErSO | 2407860-35-7 | >98% | |
ErSO is a selective anticipatory unfolded protein response (a-UPR) activator. ErSO acts through ERα to elicit strong and sustained cytotoxic activation of the a-UPR. ErSO can be used for the research of cancer. | ||||
| GC90653 | ERX-41 | 2440087-54-5 | >98.00% | |
An ER stress inducer | ||||
| GC90819 | 2,3,7,8-Tetrachlorodibenzofuran | 51207-31-9 | >90.00% | |
A polychlorinated dibenzofuran and dioxin | ||||
| GC90829 | 1-Palmitoyl-2-Pyropheophorbide a-sn-glycero-3-PC | 1287795-07-6 | >90.00% | |
A phospholipid-porphyrin conjugate | ||||
| GC91041 | Soluble Epoxide Hydrolase PROTAC 1a | - | >95.00% | |
A PROTAC that drives sEH degradation | ||||
| GC91153 | Sulfonadyn-47 | - | >98.00% | |
A dynamin inhibitor | ||||
| GC91590 | DTPD-Q | 252950-56-4 | >98.00% | |
DTPD-Q is an oxidized derivative of the antioxidant and methylphenyl substituted p-phenylenediamine DTPD. | ||||
| GC91977 | TrkB Agonist Prodrug R13 | 1609067-49-3 | >95.00% | |
TrkB agonist prodrug R13 (R13) is a prodrug form of the tropomyosin-related kinase B (TrkB) activator 7,8-dihydroxyflavone. | ||||
